Teladoc Health schedules October 28 results for Teladoc Health stock

Published on 10/20/2026 at 14:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 results are scheduled for October 28, 2026 after the close. Teladoc Health stock is at EUR 5.13, with Q2 revenue at USD 606.93 million.

Company events and operating scale

Teladoc Health announced its third-quarter reporting date on October 14, 2026.
Solo technology was installed in more than 15,000 care locations on October 7, 2026.
Teladoc Health stock trades at EUR 5.13 at 2:32 p.m. CEST at Lang & Schwarz on October 20, 2026.
Second-quarter revenue fell 4.00 percent to USD 606.93 million.

TDOC, US87918A1051, Illustration mit AI erstellt.

Teladoc Health (ISIN US87918A1051) was quoted at EUR 5.13 at Lang & Schwarz at 2:32 p.m. CEST on October 20, 2026. The company had announced on October 14 that it would release third-quarter 2026 results on October 28 after the market close, according to Teladoc Health.

What arrives on October 28?

The scheduled report is the next concrete test for a business still balancing scale against falling revenue. Teladoc Health said the third-quarter call would begin at 5:00 p.m. ET on October 28, 2026, giving investors a defined date for the next update.

Three milestones frame the update

Teladoc Health reported second-quarter revenue of USD 606.93 million on July 29, 2026, down 4.00 percent year over year, while adjusted earnings per share came in at negative USD 0.21 against a negative USD 0.25 consensus estimate, according to MarketBeat.

On October 7, 2026, Teladoc Health introduced SoloVitals and SoloScribe for its Solo enterprise platform. The company said Solo technology was installed in more than 15,000 care locations globally, while SoloVitals was scheduled for full general release in December 2026, according to Teladoc Health.

What will management need to explain?

The central issue is whether enterprise products can offset pressure in the consumer business. The second-quarter revenue decline and the October product expansion provide two measurable reference points for the October 28 discussion, while the company continues to operate in virtual primary care, chronic-care management and mental health services.

Stock quote and company profile

At Lang & Schwarz, Teladoc Health stood at EUR 5.13 at 2:32 p.m. CEST on October 20, 2026. The primary listing is on the NYSE, where the stock was last quoted at USD 5.73 on October 19, 2026 at 4:00 p.m. ET. The market capitalization was USD 1.0 billion as of October 19, 2026.

The further course of trading is shown by the continuously updated real-time quote of Teladoc Health stock.